| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Cardiovascular Research Group, Biomolecular Sciences Section, School of Biological Sciences, University of Reading, Berkshire, United Kingdom.
Correspondence to David S. Leake, Cardiovascular Research Group, Biomolecular Sciences Section, School of Biological Sciences, University of Reading, Whiteknights, PO Box 228, Reading, Berkshire, RG6 6AJ, United Kingdom. E-mail d.s.leake{at}reading.ac.uk
The oxidized low density lipoprotein (LDL) hypothesis of atherosclerosis proposes that LDL undergoes oxidation in the interstitial fluid of the arterial wall. We have shown that aggregated (vortexed) nonoxidized LDL was taken up by J774 mouse macrophages and human monocyte-derived macrophages and oxidized intracellularly, as assessed by the microscopic detection of ceroid, an advanced lipid oxidation product. Confocal microscopy showed that the ceroid was located in the lysosomes. To confirm these findings, J774 macrophages were incubated with acetylated LDL, which is internalized rapidly to lysosomes, and then incubated (chase incubation) in the absence of any LDL. The intracellular levels of oxysterols, measured by HPLC, increased during the chase incubation period, showing that LDL must have been oxidized inside the cells. Furthermore, we found that this oxidative modification was inhibited by lipid-soluble antioxidants, an iron chelator taken up by fluid-phase pinocytosis and the lysosomotropic drug chloroquine, which increases the pH of lysosomes. The results indicate that LDL oxidation can occur intracellularly, most probably within lysosomes.
Key Words: atherosclerosis ceroid lysosome iron oxidized low density lipoprotein
This article has been cited by other articles:
![]() |
J. Bouvier, K. A. Zemski Berry, F. Hullin-Matsuda, A. Makino, S. Michaud, A. Geloen, R. C. Murphy, T. Kobayashi, M. Lagarde, and I. Delton-Vandenbroucke Selective decrease of bis(monoacylglycero)phosphate content in macrophages by high supplementation with docosahexaenoic acid J. Lipid Res., February 1, 2009; 50(2): 243 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Greve and K. Wachtell Review: Does lowering cholesterol have an impact on the progression of aortic stenosis? Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 277 - 286. [Abstract] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |